The Biotechnology Innovation Organization IP Counsels Committee will be offering the next installment of its webinar series on September 29, 2021 at 1:00 pm (EDT).  In the webinar, entitled "112 Enablement: What to Watch Out For," Michael Bunis of Choate Hall & Stewart LLP will moderate a panel consisting of Stephanie Schonewald of Choate Hall & Stewart LLP, Wendy Plotkin of Biogen, and Amy Bray of Adimab, LLC.  The panel will discuss Section 112, focusing on the enablement of functional language, review how this is playing out in district court litigation and in the PTAB, and also discuss potential prosecution strategies.  The panel discussion will also focus on recent enablement-related cases, including Amgen v. Sanofi and the cases that led to that landmark decision.

The webinar is complimentary for BIO members and $99 for non-members.  Those interested in registering for the program, can do so here.